| Listed site | cdmo | cdmo |
|---|
| Summary | Global CDMO with 7,900+ employees across 18 facilities, offering integrated drug development and manufacturing services including analytical development, formulation, process development, fill-finish, and specialized chemistry capabilities. | European CDMO specializing in microbial and precision fermentation up to 40,000 L across two integrated sites (Pamplona, Spain and Basel, Switzerland), with core strengths in E. coli expression, animal health biologics, probiotics, and complex CMC programs requiring scale-up discipline and impurity control. |
|---|
| Services | - API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Process Development
- CMC Analytical Development
- Formulation Development
- Stability Testing & Storage
- Quality Control Testing
- Flow Chemistry & Continuous Manufacturing
- Peptide Manufacturing
- Oligonucleotide Manufacturing
- Oral Solid Dosage Manufacturing
- Technology Transfer
- CMC Regulatory Submission Support
- Solid-State Chemistry & Polymorph Screening
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Prefilled Syringe (PFS) Filling
- Cartridge Filling
- Lyophilization (Freeze Drying)
- Cold-Chain Storage & Logistics
- Small Molecule Development & Manufacturing
- Serialization & Track-and-Trace
- Secondary Packaging & Labeling
- Extractables & Leachables Studies
- Combination Product Assembly & Final Packaging
- Cell-Line Development
- Upstream Processing
- Downstream Processing
| - Process Development
- Upstream Processing
- Downstream Processing
- CMC Analytical Development
- Stability Testing & Storage
- CMC Regulatory Submission Support
- Technology Transfer
- Microbial Fermentation
- Recombinant Protein Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Lyophilization (Freeze Drying)
- Extractables & Leachables Studies
- Quality Control Testing
- Cell-Line Development
- mRNA Manufacturing
- Lipid Nanoparticle (LNP) Formulation
- Oligonucleotide Manufacturing
- Peptide Manufacturing
|
|---|
| Modalities | - Small Molecule
- Biologics (Other)
- Oligonucleotide
- Peptide
| - Biologics (Other)
- mRNA
- Oligonucleotide
- Peptide
- Microbiome Therapeutic
|
|---|
| Indications | Data not yet provided. | Data not yet provided. |
|---|
| Locations | - Headquarters, Belfast, Northern Ireland, United Kingdom
- US Operations, Multiple, United States, United States
- Partner Lab, Multiple, Asia, Asia
- Headquarters / UK, UK, United Kingdom
- US, US, United States
- Asia Partner Lab, Asia
- Headquarters, Craigavon, Northern Ireland, United Kingdom
- Souderton, Souderton, Pennsylvania, United States
- Singapore, Singapore, Singapore, Singapore
- Craigavon, Craigavon, Northern Ireland, United Kingdom
- North Carolina, North Carolina, North Carolina, United States
| - Headquarters, Pamplona, Navarre, Spain
- Headquarters, Basel, Basel-Stadt, Switzerland
|
|---|
| Certifications | | Data not yet provided. |
|---|
| Reviews | Review summary appears after site-level review signal gate opens. | Review summary appears after site-level review signal gate opens. |
|---|